Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30078886HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30077335HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30019550HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30044808HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30044809HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30044810HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS20003334HPVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS20044172HPVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS20066218HPVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS20017200HPVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TCGA Plot Options
Drug Information
GenePRKCA
DrugBank IDDB06451
Drug NameAprinocarsen
Target IDBE0001132
UniProt IDP17252
Regulation Type
PubMed IDs16424642; 15868384
CitationsLahn M, Sundell K, Kohler G: The role of protein kinase C-alpha in hematologic malignancies. Acta Haematol. 2006;115(1-2):1-8.@@Vansteenkiste J, Canon JL, Riska H, Pirker R, Peterson P, John W, Mali P, Lahn M: Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer. Invest New Drugs. 2005 Jun;23(3):263-9.
GroupsInvestigational
Direct Classification
SMILES
Pathways
PharmGKB
ChEMBL